Radiofrequency ablation itself generally has no effect on a patient’s life expectancy. How long a patient can live after radiofrequency ablation is generally affected by the patient’s original condition, the presence of comorbidities and complications, age and other prognostic factors, and there is no clear answer.
Radiofrequency ablation is widely used in clinical practice for the removal of solid tumors and the elimination of warts. In cardiology, radiofrequency ablation is mostly used in the treatment of arrhythmia. The principle is to use the local thermal effect of electric current to dehydrate the cardiomyocytes and form a small area of necrotic tissues with clear boundaries, so as to realize the purpose of ablating abnormal conduction pathways, but normal tissues are generally unaffected.
The prognosis for patients with arrhythmias is generally influenced by the presence of primary organic disease, the occurrence of adverse cardiovascular events such as stroke, and age. In people with indications such as arrhythmia, radiofrequency ablation is generally safe and does not affect life expectancy if there are no contraindications such as blood clots or active bleeding.
Patients undergoing radiofrequency ablation should follow the doctor’s instructions for regular review, consult a doctor if they feel unwell, and keep a good attitude.